Prof. Orla Hardiman

Prof. Orla Hardiman is one of the world's most internationally respected authorities on amyotrophic lateral sclerosis (ALS) and motor neuron disease, holding the Chair of Neurology at Trinity College Dublin and serving as a consultant neurologist at Beaumont Hospital — Ireland's national neuroscience centre. Her career, spanning more than 30 years, has been devoted to understanding and ultimately curing ALS through a combination of clinical excellence, population science, and translational genetics research.

Beaumont Hospital's ALS/MND clinic — which Prof. Hardiman leads — is recognised as one of the most comprehensive multidisciplinary ALS services in Europe, integrating neurology, respiratory medicine, physiotherapy, occupational therapy, dietetics, speech and language therapy, and palliative care under one roof. The clinic's patient-centred, multidisciplinary model has been cited internationally as best practice for ALS care and has influenced the design of ALS services in many countries.

Prof. Hardiman is the founder and director of the Irish ALS Register — one of the world's most complete population-based disease registries, capturing virtually all ALS cases in Ireland with longitudinal follow-up. The Register has provided unique epidemiological data on ALS incidence, survival, geographical clustering, and familial aggregation, and has been the foundation for important genetic discoveries including the characterisation of C9orf72 repeat expansion as the most common genetic cause of both familial ALS and frontotemporal dementia (FTD) in populations of European ancestry.

Her contributions to ALS genetics — particularly her work on C9orf72, SOD1, FUS, and TARDBP mutations and their phenotypic consequences — have been published in Nature Genetics, Lancet Neurology, and Nature Neuroscience, and have shaped the current understanding of ALS as a disease with a spectrum of genetic architectures. She is a Member of the Royal Irish Academy (MRIA) — Ireland's highest academic distinction — and has received major funding from Science Foundation Ireland and the Irish Research Council.

Prof. Hardiman completed her medical degree at University College Dublin and subsequently trained in neurology at Beaumont Hospital and through a fellowship at the Medical College of Pennsylvania in the United States, where she developed her early expertise in motor neuron disease. Her return to Ireland marked the beginning of a sustained commitment to building Irish ALS research infrastructure and clinical services.

She holds the Fellowship of the Royal College of Physicians of Ireland (FRCPI) and is a Member of the Royal Irish Academy (MRIA) — the latter being one of Ireland's highest academic honours, awarded to individuals who have made exceptional contributions to scholarship and scientific knowledge. Her professorial chair of neurology at Trinity College Dublin is accompanied by an active research group that generates both fundamental biological insights and population-based epidemiological data on neurodegenerative disease.

Prof. Hardiman's clinical practice is centred on the diagnosis, genetic characterisation, and comprehensive multidisciplinary management of ALS/MND and related neurodegenerative conditions. The diagnostic workup she performs includes detailed clinical neurological examination for upper and lower motor neuron signs, electromyography (EMG) and nerve conduction studies to confirm widespread motor neuron involvement, and genetic testing for known ALS-causing mutations — including C9orf72 repeat expansion, SOD1, FUS, and TARDBP.

She coordinates the ALS multidisciplinary clinic at Beaumont, which provides holistic management of disease complications including respiratory failure (non-invasive ventilation, NIV), dysphagia, and communication difficulties. She leads clinical trial enrolment for patients with ALS at Beaumont, providing access to investigational therapeutic agents — including antisense oligonucleotides (ASOs) and gene therapy approaches — through international trial networks. She also manages patients with frontotemporal dementia associated with ALS (FTD-ALS), working with neuropsychology and the behavioural neurology team.

Prof. Hardiman has authored and co-authored over 300 peer-reviewed publications in journals including Lancet Neurology, Nature Genetics, Nature Neuroscience, Annals of Neurology, and Brain. Her work on C9orf72 — the most common genetic cause of ALS and FTD in European populations — is among the most highly cited contributions to the ALS field and has provided the framework for understanding the genetic architecture of this disease.

The Irish ALS Register, which she designed and leads, is one of the most complete population-based disease registries for any neurological condition worldwide, and the data it has generated have underpinned dozens of epidemiological, genetic, and clinical studies. She is a recipient of Science Foundation Ireland Laureate funding — Ireland's most prestigious national research award for established investigators — and has led European Research Council-funded projects examining ALS population genetics. She serves on the editorial boards of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration and the Journal of Neurology, Neurosurgery and Psychiatry.

Beaumont Hospital's ALS/MND clinic is Ireland's national referral centre for motor neuron disease and accepts patients from across Ireland and from other countries seeking specialist diagnosis, second opinions, or enrolment in clinical trials. Prof. Hardiman consults exclusively in English. For patients outside Ireland who have received or suspect an ALS diagnosis, video consultations are available to review clinical findings, EMG reports, and neuroimaging before a decision is made about travelling to Dublin.

The ALS multidisciplinary clinic at Beaumont is designed to provide comprehensive assessment in a single visit, minimising the burden on patients and families who may have already endured significant hardship. EU/EEA patients can use their EHIC for eligible treatments. Dublin is accessible by direct flight from most major European cities, and Beaumont Hospital is located close to Dublin Airport in north Dublin, making logistics particularly practical for international patients.

Prof. Hardiman's contributions to neurology, genetics, and public health have been recognised with the highest awards available in Irish academic medicine. She was awarded the Royal Academy of Medicine in Ireland (RAMI) Gold Medal — the academy's most prestigious individual honour — for her transformative contributions to neuroscience and public health. She is a Member of the Royal Irish Academy (MRIA), Ireland's highest academic body, recognising exceptional scholarly achievement. She received the Irish Research Council SFI Laureate Award — Ireland's most substantial national research grant for established researchers — and has been recognised by Trinity College Dublin with its Research Award for sustained academic excellence. The World Federation of Neurology honoured her with the ALS Prize for her lifetime contributions to motor neuron disease research.